Trials to Test Pot-Infused Chewing Gum for MS Sufferers

Warning message

The subscription service is currently unavailable. Please try again later.

Clinical trials have begun to see if cannabis-infused chewing gum could be used to relieve pain and spasticity in multiple sclerosis patients.

A number of multiple sclerosis sufferers have turned to marijuana to ease the pain and symptoms of the debilitating disease.

A New York-based biotech company is hoping that some relief from the pain and spasticity of MS is just a stick of cannabis gum away.

AXIM Biotech recently announced it will begin a series of clinical trials of its patented cannabinoid controlled-release chewing gum. The trials for MedChew RX gum, which contains 5 milligrams of cannabidiol, a nonpsychoactive component of cannabis, and 5 milligrams of THC, a psychoactive cannabinoid, will be carried out in Europe.

 Find help for common financial problems in our Solutions Center!

The biotech company hopes that the marijuana-infused chewing gum will provide a discrete, safe and effective pain-management medication for MS patients....

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.moneytalksnews.com/trials-test-pot-infused-chewing-gum-for-sufferers/